Yiftach Roth - 01 Jun 2026 Form 4 Insider Report for Brainsway Ltd. (BWAY)

Reporting relationship: Chief Scientist
Issuer ticker: BWAY
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2026, 16:02:15 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Yiftach Roth

Key filing fact

Yiftach Roth filed Form 4 for Brainsway Ltd. (BWAY) on 03 Jun 2026.

Key facts

This page summarizes Yiftach Roth's Form 4 filing for Brainsway Ltd. (BWAY).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2026, 16:02.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111635 Primary reporting owner

Roth Yiftach

Relationship: Chief Scientist
Address: 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, JERUSALEM, ISRAEL
Signature: /s/ Yiftach Roth
Signature date: 03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares: -2,000
Change %: -0.19%
Price
Shares after: 1,077,305
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F1, F2, F3

BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares: -2,000
Change %: -0.19%
Price
Shares after: 1,075,305
Date: 01 Jun 2026
Ownership: Direct
Footnotes: F1, F3, F4

BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares: -1,000
Change %: -0.09%
Price
Shares after: 1,074,305
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F3, F5

BWAY transaction

Ordinary Shares

Sale

Transaction value
Shares: -2,000
Change %: -0.19%
Price
Shares after: 1,072,305
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F3, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.

Footnote F2

The sale price was NIS 43.64 per share.

Footnote F3

This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share.